Showing results (661-670 of 709) with videos related to

Sort By:
Pageof 71
British Journal of Cancer|February 3, 2021
Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumabAndrew X Zhu, Richard S Finn, Yoon-Koo Kang, et al.
JHEP Reports : Innovation in Hepatology|January 4, 2021
Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2Masatoshi Kudo, Peter R Galle, Giovanni Brandi, et al.
Genetics|September 3, 1999
An exploration of the sequence of a 2.9-Mb region of the genome of Drosophila melanogaster: the Adh regionM Ashburner, S Misra, J Roote, et al.
Hepatology International|March 7, 2026
Immune biomarkers predicting response to G-CSF in acute-on-chronic liver failure: results from a GRAFT trial sub-studyKatrin Splith, Nadja Berndt, Philipp K Haber, et al.
BMC Cancer|April 13, 2012
LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trialCarl Christoph Schimanski, Markus Möhler, Michael Schön, et al.
International Journal of Cancer|November 29, 2018
Application of patient-derived liver cancer cells for phenotypic characterization and therapeutic target identificationDarko Castven, Diana Becker, Carolin Czauderna, et al.
BMC Cancer|September 2, 2016
Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker programMarkus Moehler, Irina Gepfner-Tuma, Annett Maderer, et al.
Digestive Diseases and Sciences|June 11, 2009
Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patientsMartin H Holtmann, Frank Krummenauer, Christina Claas, et al.
Digestive Diseases and Sciences|August 24, 2006
Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patientsMartin H Holtmann, Frank Krummenauer, Christina Claas, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programmeM Moehler, A Maderer, C Schimanski, et al.
Pageof 71